Accutane (isotretinoin) works long term by triggering a programmed self-destruction of the oil-producing cells in your skin, effectively shrinking and resetting the glands that fuel acne. Unlike other acne treatments that manage symptoms while you take them, isotretinoin is the only acne medication that can produce lasting remission after a single course. About 73% of patients treated with adequate doses stay clear long term, though the results depend heavily on how much total medication you receive.
How It Shrinks Oil Glands Permanently
Your skin’s oil glands, called sebaceous glands, are the root of severe acne. They overproduce oil, which clogs pores and feeds acne-causing bacteria. Isotretinoin doesn’t just reduce oil temporarily. It activates a process called apoptosis, which is essentially a self-destruct signal that causes oil-producing cells to die off in an orderly way. The drug ramps up production of specific proteins that trigger this cell death, and the result is a dramatic, lasting reduction in the size and output of your oil glands.
At the gene level, isotretinoin significantly increases the activity of p53, a well-known tumor-suppressor protein, within the sebaceous glands. This heightened p53 activity switches on a cascade of downstream signals that suppress oil production at its source. It controls how your skin cells respond to hormones, how they recycle damaged components, and whether they live or die. Research published in Archives of Dermatological Research confirmed that isotretinoin-treated patients showed significantly higher p53 activity in their oil glands compared to both their own pre-treatment levels and untreated controls.
This isn’t a simple on-off switch. Depending on the dose and duration of treatment, isotretinoin can push oil gland cells toward either autophagy (where cells digest their own damaged parts and remodel) or full apoptosis (where cells die entirely). Both pathways contribute to the long-term shrinkage of oil glands that keeps acne from returning.
It Reduces Your Skin’s Sensitivity to Hormones
Androgens, the hormones that drive oil production and fuel acne, act on your skin through androgen receptors. Isotretinoin reduces the number of these receptors in your skin by roughly 2.6-fold without changing how tightly hormones bind to them. In practical terms, the same amount of circulating hormones produces a much weaker signal in the skin after treatment. Your hormone levels stay the same, but your skin stops overreacting to them. This helps explain why the benefits persist even after the drug has completely left your body.
It Resets Your Skin’s Bacterial Community
By dramatically cutting oil production, isotretinoin creates what researchers describe as a “population bottleneck” for the bacteria living on your skin. The specific strains of Cutibacterium acnes most associated with acne breakouts decline sharply during treatment. But not all skin bacteria are affected equally. Strains associated with healthy skin actually increase during and after treatment, while acne-linked strains are suppressed.
This shift in bacterial communities persists after treatment ends. The new, healthier mix of skin bacteria that emerges during isotretinoin therapy tends to remain in place, contributing to the long-term remission. It’s essentially a reset of the skin’s ecosystem, not just a temporary sterilization.
How Long the Results Last
For most people, a single course of isotretinoin produces years of clear skin, and for many, the results are permanent. The relapse rate depends significantly on the total cumulative dose. In a study published in JAMA Dermatology, patients who received a higher cumulative dose (220 mg/kg or more over their full course) had a relapse rate of about 27%, compared to 47% for those who received less. The traditional target of 120 to 150 mg/kg total has been the standard guideline for decades, though a 2016 review found that this threshold is based on older studies with inconsistent definitions of “remission” and that the optimal dose likely varies with acne severity.
When acne does return after treatment, it’s often milder than the original breakouts and can frequently be managed with topical treatments or antibiotics. Only about 1.7% of patients in the JAMA study required a full retrial of isotretinoin. A second course, when needed, tends to be just as effective as the first.
Lasting Side Effects to Know About
The same mechanism that shrinks oil glands in your skin also affects oil-producing glands elsewhere in the body, particularly the meibomian glands in your eyelids that keep your eyes lubricated. Research tracking patients before, during, and after treatment found that dry eye symptoms increased significantly during isotretinoin use and remained elevated above baseline even after stopping the drug. The structure of the meibomian glands showed measurable changes: gland loss increased during treatment and, while it improved somewhat after stopping, did not fully return to pre-treatment levels.
Other commonly reported side effects during treatment, including joint pain, muscle pain, headaches, and temporary hair loss (occurring in about 13% of patients), are generally reversible and resolve after treatment ends. The dryness of skin and lips that most patients experience during their course is a direct and expected consequence of the drug’s core mechanism and typically fades within weeks to months of finishing.
The eye-related changes deserve particular attention if you wear contact lenses or already have dry eyes. While most patients’ eye comfort improves after completing treatment, some experience persistent dryness that may require ongoing use of artificial tears.
Why the Effects Outlast the Drug
Isotretinoin is fully cleared from your body within about a month of your last dose. Yet its effects persist for years or permanently in most patients. This durability comes from the combination of structural and biological changes the drug produces: physically smaller oil glands with fewer cells, reduced androgen receptor density in the skin, a shifted bacterial ecosystem favoring healthy strains, and altered gene expression patterns that suppress the pathways driving oil overproduction. None of these changes depend on the continued presence of the drug. They represent a genuine remodeling of the skin’s biology rather than an ongoing suppression of symptoms.